At month 9, all the 7 evaluable patients showed improvement/slower progression in neuropathy versus disease natural history.117NI301A is a recombinant human monoclonal immunoglobulin G1 that binds selectively with high affinity to the disease-associated ATTR amyloid deposits. This evidence concerns the gene TTR and neuropathy.